vs

Side-by-side financial comparison of Angel Oak Mortgage REIT, Inc. (AOMR) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

Sol-Gel Technologies Ltd. is the larger business by last-quarter revenue ($17.3M vs $10.9M, roughly 1.6× Angel Oak Mortgage REIT, Inc.). Angel Oak Mortgage REIT, Inc. runs the higher net margin — 103.9% vs 67.3%, a 36.6% gap on every dollar of revenue. On growth, Sol-Gel Technologies Ltd. posted the faster year-over-year revenue change (217.7% vs 10.4%).

Angel Oak Mortgage REIT, Inc. is a U.S.-based real estate investment trust focused on investing in residential mortgage assets, including non-agency mortgage-backed securities, residential mortgage loans, and credit-linked real estate instruments. It serves U.S. institutional and retail investors, targeting competitive risk-adjusted returns through regular income and long-term capital growth.

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

AOMR vs SLGL — Head-to-Head

Bigger by revenue
SLGL
SLGL
1.6× larger
SLGL
$17.3M
$10.9M
AOMR
Growing faster (revenue YoY)
SLGL
SLGL
+207.3% gap
SLGL
217.7%
10.4%
AOMR
Higher net margin
AOMR
AOMR
36.6% more per $
AOMR
103.9%
67.3%
SLGL

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
AOMR
AOMR
SLGL
SLGL
Revenue
$10.9M
$17.3M
Net Profit
$11.3M
$11.6M
Gross Margin
Operating Margin
65.1%
Net Margin
103.9%
67.3%
Revenue YoY
10.4%
217.7%
Net Profit YoY
175.2%
487.6%
EPS (diluted)
$0.44
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AOMR
AOMR
SLGL
SLGL
Q4 25
$10.9M
Q3 25
$10.2M
Q2 25
$9.9M
$17.3M
Q1 25
$10.1M
Q4 24
$9.9M
Q3 24
$9.0M
Q2 24
$9.5M
$5.4M
Q1 24
$8.6M
Net Profit
AOMR
AOMR
SLGL
SLGL
Q4 25
$11.3M
Q3 25
$11.4M
Q2 25
$767.0K
$11.6M
Q1 25
$20.5M
Q4 24
$-15.1M
Q3 24
$31.2M
Q2 24
$-273.0K
$2.0M
Q1 24
$12.9M
Operating Margin
AOMR
AOMR
SLGL
SLGL
Q4 25
Q3 25
Q2 25
7.7%
65.1%
Q1 25
Q4 24
-152.6%
Q3 24
Q2 24
-1.4%
29.9%
Q1 24
Net Margin
AOMR
AOMR
SLGL
SLGL
Q4 25
103.9%
Q3 25
112.1%
Q2 25
7.7%
67.3%
Q1 25
203.5%
Q4 24
-152.6%
Q3 24
345.9%
Q2 24
-2.9%
36.4%
Q1 24
150.1%
EPS (diluted)
AOMR
AOMR
SLGL
SLGL
Q4 25
$0.44
Q3 25
$0.46
Q2 25
$0.03
$4.17
Q1 25
$0.87
Q4 24
$-0.62
Q3 24
$1.29
Q2 24
$-0.01
$0.71
Q1 24
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AOMR
AOMR
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$41.6M
$24.3M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$267.5M
$31.9M
Total Assets
$2.7B
$39.3M
Debt / EquityLower = less leverage
8.51×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AOMR
AOMR
SLGL
SLGL
Q4 25
$41.6M
Q3 25
$51.6M
Q2 25
$40.5M
$24.3M
Q1 25
$38.7M
Q4 24
$40.8M
Q3 24
$42.1M
Q2 24
$44.0M
$26.5M
Q1 24
$39.4M
Total Debt
AOMR
AOMR
SLGL
SLGL
Q4 25
$2.3B
Q3 25
$2.2B
Q2 25
Q1 25
Q4 24
$1.8B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AOMR
AOMR
SLGL
SLGL
Q4 25
$267.5M
Q3 25
$264.2M
Q2 25
$246.4M
$31.9M
Q1 25
$251.5M
Q4 24
$239.0M
Q3 24
$265.1M
Q2 24
$255.8M
$34.9M
Q1 24
$263.3M
Total Assets
AOMR
AOMR
SLGL
SLGL
Q4 25
$2.7B
Q3 25
$2.6B
Q2 25
$2.6B
$39.3M
Q1 25
$2.7B
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$2.1B
$42.0M
Q1 24
$2.3B
Debt / Equity
AOMR
AOMR
SLGL
SLGL
Q4 25
8.51×
Q3 25
8.37×
Q2 25
Q1 25
Q4 24
7.62×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AOMR
AOMR
SLGL
SLGL
Operating Cash FlowLast quarter
$-407.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-35.96×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AOMR
AOMR
SLGL
SLGL
Q4 25
$-407.0M
Q3 25
$-173.4M
Q2 25
$20.6M
Q1 25
$-201.7M
Q4 24
$-221.5M
Q3 24
$-212.4M
Q2 24
$-24.2M
Q1 24
$40.2M
Cash Conversion
AOMR
AOMR
SLGL
SLGL
Q4 25
-35.96×
Q3 25
-15.19×
Q2 25
26.92×
Q1 25
-9.83×
Q4 24
Q3 24
-6.81×
Q2 24
Q1 24
3.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AOMR
AOMR

Nonrelated Party$6.4M59%
Other$4.5M41%

SLGL
SLGL

Segment breakdown not available.

Related Comparisons